Skip to main content
. 2018 May 16;103(7):2720–2727. doi: 10.1210/jc.2018-00511

Table 1.

Association of Patient, Tumor, and Initial Treatment Characteristics With Treatment-Free Survival

Characteristic N (%) AHR (95% CI)
Patient characteristic
 Age, y
  Median (range) 69 (21–98) 1.00 (0.99–1.00)
 Sex
  Female 6938 (74.8) 1 (Reference)
  Male 2335 (25.2) 1.35 (1.20–1.52)
 Race
  White 7613 (82.1) 1 (Reference)
  Black 680 (7.3) 1.06 (0.85–1.34)
  Other 980 (10.6) 1.07 (0.90–1.27)
 Percentage with high school education only
  <20% 2195 (23.7) 1 (Reference)
  20%–29.9% 3168 (34.2) 0.95 (0.82–1.10)
  ≥30% 3554 (38.3) 0.92 (0.79–1.08)
  Unknown 356 (3.8)
 Household income
  <$35,000 1627 (17.6) 1.03 (0.86–1.23)
  $35,000–$59,000 4188 (45.2) 1.03 (0.90–1.18)
  ≥$60,000 3098 (33.4) 1 (Reference)
  Unknown 360 (3.9)
Tumor characteristic
 Stage
  Localized 6920 (74.6) 1 (Reference)
  Regional 1902 (20.5) 2.13 (1.82–2.49)
  Distant 451 (4.9) 4.43 (3.68–5.33)
 Histology
  Follicular 763 (8.2) 1.19 (0.99–1.44)
  Hürthle cell 518 (5.6) 1.36 (1.09–1.69)
  Papillary 7992 (86.2) 1 (Reference)
 Tumor size
  ≤1 cm 3580 (38.6) 1 (Reference)
  >1 cm and ≤2 cm 2082 (22.5) 1.36 (1.14–1.62)
  >2 cm and ≤4 cm 1972 (21.3) 1.69 (1.43–2.01)
  >4 cm 1213 (13.1) 2.11 (1.74–2.55)
  Unknown 426 (4.6) 2.00 (1.56–2.57)
Initial treatment characteristic
 Surgery
  Lobectomy 1922 (20.7) 0.88 (0.73–1.05)
  Total thyroidectomy 7351 (79.3) 1 (Reference)
 Lymph node resection
  Not resected 6047 (65.2) 1.01 (0.87–1.18)
  Resected and negative 2065 (22.3) 1 (Reference)
  Resected and positive 1161 (12.5) 1.38 (1.14–1.67)
 Radioactive iodine
  No 5569 (60.1) 1 (Reference)
  Yes 3704 (39.9) 1.47 (1.29–1.68)
 Radiation
  No 8918 (96.2) 1 (Reference)
  Yes 355 (3.8) 1.68 (1.33–2.12)

Abbreviation: AHR, adjusted hazard ratio.